No Data
No Data
Cero Therapeutics Announces Progress in Initiation of Phase 1 Trial
Express News | Cero Therapeutics Holdings, Inc. Announces Progress in Initiation of Phase 1 Clinical Trial by Executing an Agreement With Contract Research Organization Cellcarta to Manage Translational Assays
CERo Therapeutics Holdings, Inc. Announces Progress in Initiation of Phase 1 Clinical Trial by Executing an Agreement With Contract Research Organization CellCarta to Manage Translational Assays
CERo Therapeutics to Present Preclinical Data on CER-1236 for Ovarian Cancer at SITC Conference
CERo Therapeutics Holdings To Present Data At The Society For Immunotherapy Of Cancer Spring Scientific March 12-14, 2025
Cero Therapeutics Reports Current Cash Position of $8M
Unlock the Full List